Benztropine Mesylate en es it fr

Benztropine Mesylate Brand names, Benztropine Mesylate Analogs

Benztropine Mesylate Brand Names Mixture

  • No information avaliable

Benztropine Mesylate Chemical_Formula

C21H25NO

Benztropine Mesylate RX_link

http://www.rxlist.com/cgi/generic2/benztrop.htm

Benztropine Mesylate fda sheet

Benztropine Mesylate msds (material safety sheet)

Benztropine Mesylate Synthesis Reference

No information avaliable

Benztropine Mesylate Molecular Weight

307.429 g/mol

Benztropine Mesylate Melting Point

No information avaliable

Benztropine Mesylate H2O Solubility

Very soluble

Benztropine Mesylate State

Solid

Benztropine Mesylate LogP

4.987

Benztropine Mesylate Dosage Forms

Tablet

Benztropine Mesylate Indication

For use as an adjunct in the therapy of all forms of parkinsonism and also for use in the control of extrapyramidal disorders due to neuroleptic drugs.

Benztropine Mesylate Pharmacology

Benztropine is an anticholinergic used in the symptomatic treatment of all etiologic groups of parkinsonism and drug induced extrapyramidal reactions (except tardive dyskinesia). Benztropine possesses both anticholinergic and antihistaminic effects, although only the former has been established as therapeutically significant in the management of parkinsonism. Benztropine's anticholinergic activity is about equal to that of atropine.

Benztropine Mesylate Absorption

No information avaliable

Benztropine Mesylate side effects and Toxicity

Signs of overdose include confusion, nervousness, listlessness, hallucinations, dizziness; muscle weakness, ataxia, dry mouth, mydriasis, blurred vision, palpitations, tachycardia, elevated blood pressure, nausea, vomiting, dysuria, numbness of fingers, headache, delirium, coma, shock, convulsions, respiratory arrest, anhidrosis, hyperthermia, glaucoma, and constipation.

Benztropine Mesylate Patient Information

No information avaliable

Benztropine Mesylate Organisms Affected

Humans and other mammals